The Wistar Institute and Batavia Biosciences have launched a strategic collaboration aimed to streamline the clinical grade manufacture and global distribution of Wistar’s rubella vaccine seed stock commonly known as RA 27/3. In December 2019, Wistar was awarded a $1 million grant from the Bill & Melinda Gates Foundation to support this global access-focused international collaboration.   Rubella is a contagious viral disease that mainly affects children and young adults, typically manifeste...